BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 18175664)

  • 1. Iron supplementation and oxidative stress in patients with uremia.
    Shetty JK; Prakash M
    Indian J Physiol Pharmacol; 2007; 51(2):179-82. PubMed ID: 18175664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein thiol oxidation and lipid peroxidation in patients with uraemia.
    Prakash M; Upadhya S; Prabhu R
    Scand J Clin Lab Invest; 2004; 64(6):599-604. PubMed ID: 15370466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum non-transferrin bound iron in hemodialysis patients not receiving intravenous iron.
    Prakash M; Upadhya S; Prabhu R
    Clin Chim Acta; 2005 Oct; 360(1-2):194-8. PubMed ID: 15979061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduction of urinary thiols in nephrotic syndrome--a possible effect of free iron.
    Sinha I; Ghosh S; Dey P; Jacob J; Banerjee D
    Clin Chim Acta; 2005 May; 355(1-2):91-6. PubMed ID: 15820482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous iron, inflammation, and oxidative stress: is iron a friend or an enemy of uremic patients?
    Garneata L
    J Ren Nutr; 2008 Jan; 18(1):40-5. PubMed ID: 18089442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antioxidant enzymes show adaptation to oxidative stress in athletes and increased stress in hemodialysis patients.
    Knap B; Prezelj M; Buturović-Ponikvar J; Ponikvar R; Bren AF
    Ther Apher Dial; 2009 Aug; 13(4):300-5. PubMed ID: 19695063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipid peroxidation in hemodialysis patients: effect of vitamin C supplementation.
    Ferretti G; Bacchetti T; Masciangelo S; Pallotta G
    Clin Biochem; 2008 Apr; 41(6):381-6. PubMed ID: 18194672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathological role of aminolevulinate in uremic patients.
    Hasuike Y; Nonoguchi H; Tokuyama M; Hata R; Kitamura R; Hori K; Nanami M; Otaki Y; Kuragano T; Nakanishi T
    Ther Apher Dial; 2011 Feb; 15(1):28-33. PubMed ID: 21272249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxidative stress in elderly chronic renal failure patients: effects of renal replacement therapies on cell membrane fluidity.
    Goi G; Massaccesi L; Baquero Herrera CJ; Musetti C; Ciurlino D; Cusi D; Bertoli S
    J Nephrol; 2009; 22(5):630-6. PubMed ID: 19809996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erythropoiesis activity, iron availability and reticulocyte hemoglobinization during treatment with hemodialysis and in subjects with uremia.
    Schoorl M; Schoorl M; Nubé MJ; Bartels PC
    Clin Lab; 2006; 52(11-12):621-9. PubMed ID: 17175894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxidative stress and uremia.
    Floccari F; Aloisi C; Crascì E; Sofi T; Campo S; Tripodo D; Criseo M; Frisina N; Buemi M
    Med Res Rev; 2005 Jul; 25(4):473-86. PubMed ID: 15660443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dialyzable uremic solutes contribute to enhanced oxidation of serum albumin in regular hemodialysis patients.
    Terawaki H; Nakayama K; Matsuyama Y; Nakayama M; Sato T; Hosoya T; Era S; Ito S
    Blood Purif; 2007; 25(3):274-9. PubMed ID: 17460395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Daily supplementation with iron increases lipid peroxidation in young women with low iron stores.
    King SM; Donangelo CM; Knutson MD; Walter PB; Ames BN; Viteri FE; King JC
    Exp Biol Med (Maywood); 2008 Jun; 233(6):701-7. PubMed ID: 18408148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous iron sucrose in Chinese hemodialysis patients with renal anemia.
    Li H; Wang SX
    Blood Purif; 2008; 26(2):151-6. PubMed ID: 18212498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relevance of oxidative pathways in the pathophysiology of chronic kidney disease.
    Himmelfarb J
    Cardiol Clin; 2005 Aug; 23(3):319-30. PubMed ID: 16084281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alterations in trace elements and oxidative stress in uremic patients with dementia.
    Guo CH; Ko WS; Chen PC; Hsu GS; Lin CY; Wang CL
    Biol Trace Elem Res; 2009 Oct; 131(1):13-24. PubMed ID: 19242659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxidative stress in uremia: the role of anemia correction.
    Lahera V; Goicoechea M; de Vinuesa SG; Oubiña P; Cachofeiro V; Gómez-Campderá F; Amann R; Luño J
    J Am Soc Nephrol; 2006 Dec; 17(12 Suppl 3):S174-7. PubMed ID: 17130258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxidative stress parameters in hemodialysis patients with or without diabetes.
    Atanasiu V; Stoian I; Căpuşă C; Mircescu G; Mărăcine M; Lupescu O; Vîrgolici B; Muscurel C; Manolescu B
    Rom J Intern Med; 2006; 44(4):433-42. PubMed ID: 18386620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxidative stress and delta-ALA-D activity in chronic renal failure patients.
    da Silva AC; Rocha JB; Morsch AL; Zanin RF; Kaizer R; Maldonado PA; Arantes LC; Silva LA; Morsch VM; Schetinger MR
    Biomed Pharmacother; 2007; 61(2-3):180-5. PubMed ID: 17383846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.